0001996977-26-000001.txt : 20260603 0001996977-26-000001.hdr.sgml : 20260603 20260603171400 ACCESSION NUMBER: 0001996977-26-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: Rule 506(b) provides a "safer harbor" for a private offering FILED AS OF DATE: 20260603 DATE AS OF CHANGE: 20260603 EFFECTIVENESS DATE: 20260603 FILER: COMPANY DATA: COMPANY CONFORMED NAME: iQure Pharma Inc. CENTRAL INDEX KEY: 0001996977 ORGANIZATION NAME: EIN: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-586117 FILM NUMBER: 261061982 BUSINESS ADDRESS: STREET 1: 3 KITTANSETT COURT CITY: SKILLMAN STATE: NJ ZIP: 08558 BUSINESS PHONE: 3127411606 MAIL ADDRESS: STREET 1: 3 KITTANSETT COURT CITY: SKILLMAN STATE: NJ ZIP: 08558 D 1 primary_doc.xml X0708 D LIVE 0001996977 iQure Pharma Inc. 3 KITTANSETT COURT SKILLMAN NJ NEW JERSEY 08558 3122911382 DELAWARE None None Corporation true Pawel Zolnierczyk 3 KITTANSETT COURT SKILLMAN NJ NEW JERSEY 08558 Executive Officer Other Decline to Disclose 06b false 2026-05-27 false true false 0 4000000 650000 3350000 false 1 0 0 0 false iQure Pharma Inc. Pawel Zolnierczyk Pawel Zolnierczyk President, CEO 2026-06-03